FDA Nominee Addresses Vaccine Safety During Senate Hearing

Why it matters locally: The FDA's stance on vaccine safety and childhood immunizations, as discussed by its nominee, could influence public health policy and vaccine distribution strategies within Wisconsin, affecting state residents and healthcare providers.

---

WASHINGTON – Heidi Overton, President Donald Trump's nominee to lead the Food and Drug Administration (FDA), spoke to senators Thursday during her confirmation hearing. Overton addressed the safety of long-established vaccines. Senators questioned Overton on the White House's initiatives regarding childhood immunizations. Her testimony followed President Trump's nomination for the FDA's top role.